Maria Kalli Email

Microfluidics Engineer . MicrofluidX

Current Roles

Employees:
44
Revenue:
$11.2M
About
The MicrofluidX technology platform is a revolutionary platform for cell and gene therapy manufacturing. Our key objectives are to reduce production cost by 60-90%, reduce investment costs for new production facilities by 50-70%, enable virtually infinite process scalability through the pre-clinical, clinical and commercial phases of the therapeutic development and increase final product quality and stability.
MicrofluidX Address
Stevenage Bioscience Catalyst
London, London
MicrofluidX Email